FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3028913968> ?p ?o ?g. }

• W3028913968 endingPage "224" @default.
• W3028913968 startingPage "217" @default.
• W3028913968 abstract "BackgroundThe pathogenesis mechanism of diabetic cataract has not been fully elucidated.Researches showed that multiple biological pathways participate in the pathogenesis of diabetic cataract, including oxidative stress.Astaxanthin can inhibit oxidative stress-mediated injury and lipid peroxidation.However, whether astaxanthin has the preventive effects on diabetic cataract is unclear.ObjectiveThis study was to investigate the preventive effects of astaxanthin on metabolic cataract in type 1 diabetic rats.MethodsThirty-eight 6-week-old SPF male SD rats were used in this study, and 1% streptozocin was intraperitoneally injected to establish type 1 diabetic models in 30 rats, and 24 successful models were assigned to diabetic model group, low-dose astaxanthin group and high-dose astaxanthin group.Equal volume of normal saline solution was injected in the same way in 8 rats as the normal control group.Mixture foods containing 50 mg/(kg·day) or 100 mg/(kg·day) astaxanthin with olive oil and fodder were used continuously for 3 months in the rats of low-dose astaxanthin group and high-dose astaxanthin group, respectively, and mixture food of olive oil with fodder was used in the diabetic model group.Only fodder was used in the same way in the rats of the normal control group.The opacification of lens was examined by slit lamp section radiography system and graded on a scale of 1-5.The specimen of lens were prepared for the hematoxylin & eosin stain.The expression and lation of advanced glycosylation end products (AGEs) in the lens was examined using immunochemistry.The contents of oxidative stress-related indicators in the lens, such as AGEs, malonydialdehyde (MDA), catalase (CAT), superoxide dismutase (SOD) and mass fraction of glutathione (GSH), were assayed by ELISA.The experimental process complied with the national standard (Laboratory Animal Requirements of Environment and Housing Facilities [GB14925-2001]).ResultsThe blood glucose levels of the rats were significantly higher in the diabetic model group, low-dose astaxanthin group and high-dose astaxanthin group than those in the normal control group at 2, 4, 6, 8, 10 and 12 weeks after modeling (all at P 0.05). The rat lenses were transparent in the normal control group with scale of grade 1, and serious lens opacification was seen in the rats of the diabatic model group, with the scale of grade 5, while the rat lenses in the low-dose astaxanthin group and high-dose astaxanthin group were in grade 3-4.The contents of AGEs in the lenses were (7.23±0.50)μg/ml and (7.01±0.37)μg/ml, and MDA contents were (1.43 ±0.22)mmol/L and (1.35±0.16)mmol/L in the low-dose astaxanthin group and high-dose astaxanthin group respectively, which were significantly lower than (7.61± 0.45)μg/ml and (1.62±0.42)mmol/L in the normal control group (all at P<0.05). GSH contents in rat lenes were (272.70±12.53)ng/L and (283.52±16.17)ng/L, and SOD concents were (55.45±6.47)μmol/(min·L) and (56.73±5.12)μmol/(min·L), and CAT concents were (2.91±0.41)μmol/(min·L) and (3.02±0.13)μmol/ (min·L) in the low-dose astaxanthin group and high-dose astaxanthin group respectively, which were significantly higher than (241.52±15.13)ng/L, (51.67±5.45)μmol/(min·L) and (2.72±0.27)μmol/(min·L) in the normal control group (all at P<0.05). The GSH concent and SOD concent in rat lens were lower in the low-dose astaxanthin group than that in the high-dose astaxanthin group (both at P<0.05).ConclusionsAstaxanthin can postpone the pathogenesis and development of diabetic cataract in type 1 diabetic rats by antioxydative stress.Key words: Antioxidants/pharmacology; Carotenoid astaxanthin; Diabetes mellitus, experimental/complications; Diabetic cataract/drug therapy; Oxidative stress; Rats, SD" @default.
• W3028913968 created "2020-06-05" @default.
• W3028913968 creator A5000179320 @default.
• W3028913968 creator A5002196970 @default.
• W3028913968 creator A5025082076 @default.
• W3028913968 creator A5075523270 @default.
• W3028913968 date "2017-03-10" @default.
• W3028913968 modified "2023-09-23" @default.
• W3028913968 title "Proventive effects of astaxanthin on metabolic cataract and its mechanism in type 1 diabetic rats" @default.
• W3028913968 doi "https://doi.org/10.3760/cma.j.issn.2095-0160.2017.03.007" @default.
• W3028913968 hasPublicationYear "2017" @default.
• W3028913968 type Work @default.
• W3028913968 sameAs 3028913968 @default.
• W3028913968 citedByCount "0" @default.
• W3028913968 crossrefType "journal-article" @default.
• W3028913968 hasAuthorship W3028913968A5000179320 @default.
• W3028913968 hasAuthorship W3028913968A5002196970 @default.
• W3028913968 hasAuthorship W3028913968A5025082076 @default.
• W3028913968 hasAuthorship W3028913968A5075523270 @default.
• W3028913968 hasConcept C126322002 @default.
• W3028913968 hasConcept C134018914 @default.
• W3028913968 hasConcept C185592680 @default.
• W3028913968 hasConcept C2776151105 @default.
• W3028913968 hasConcept C2779829184 @default.
• W3028913968 hasConcept C2780942790 @default.
• W3028913968 hasConcept C2780962900 @default.
• W3028913968 hasConcept C28781525 @default.
• W3028913968 hasConcept C55493867 @default.
• W3028913968 hasConcept C555293320 @default.
• W3028913968 hasConcept C71924100 @default.
• W3028913968 hasConcept C98274493 @default.
• W3028913968 hasConceptScore W3028913968C126322002 @default.
• W3028913968 hasConceptScore W3028913968C134018914 @default.
• W3028913968 hasConceptScore W3028913968C185592680 @default.
• W3028913968 hasConceptScore W3028913968C2776151105 @default.
• W3028913968 hasConceptScore W3028913968C2779829184 @default.
• W3028913968 hasConceptScore W3028913968C2780942790 @default.
• W3028913968 hasConceptScore W3028913968C2780962900 @default.
• W3028913968 hasConceptScore W3028913968C28781525 @default.
• W3028913968 hasConceptScore W3028913968C55493867 @default.
• W3028913968 hasConceptScore W3028913968C555293320 @default.
• W3028913968 hasConceptScore W3028913968C71924100 @default.
• W3028913968 hasConceptScore W3028913968C98274493 @default.
• W3028913968 hasIssue "3" @default.
• W3028913968 hasLocation W30289139681 @default.
• W3028913968 hasOpenAccess W3028913968 @default.
• W3028913968 hasPrimaryLocation W30289139681 @default.
• W3028913968 hasRelatedWork W1511915285 @default.
• W3028913968 hasRelatedWork W2350379382 @default.
• W3028913968 hasRelatedWork W2359165804 @default.
• W3028913968 hasRelatedWork W2360336457 @default.
• W3028913968 hasRelatedWork W2360944692 @default.
• W3028913968 hasRelatedWork W2365608119 @default.
• W3028913968 hasRelatedWork W2369175115 @default.
• W3028913968 hasRelatedWork W2375184857 @default.
• W3028913968 hasRelatedWork W2378684211 @default.
• W3028913968 hasRelatedWork W2380693617 @default.
• W3028913968 hasRelatedWork W2381847529 @default.
• W3028913968 hasRelatedWork W2390783726 @default.
• W3028913968 hasRelatedWork W2392319830 @default.
• W3028913968 hasRelatedWork W2538550250 @default.
• W3028913968 hasRelatedWork W2598309755 @default.
• W3028913968 hasRelatedWork W2810020893 @default.
• W3028913968 hasRelatedWork W2995003776 @default.
• W3028913968 hasRelatedWork W2999066099 @default.
• W3028913968 hasRelatedWork W3045337930 @default.
• W3028913968 hasRelatedWork W3177187147 @default.
• W3028913968 hasVolume "35" @default.
• W3028913968 isParatext "false" @default.
• W3028913968 isRetracted "false" @default.
• W3028913968 magId "3028913968" @default.
• W3028913968 workType "article" @default.